PURPOSE: To evaluate the association of body size-captured via whole-body dual-energy X-ray absorptiometry (DXA) and physical measurement-with serum sex steroid hormones and sex hormone binding globulin (SHBG), we utilized cross-sectional data and serum samples from the National Health and Nutrition Examination Survey (NHANES; 1999-2004). METHODS:Testosterone, androstanediol glucuronide (3-alpha-diol-G), estradiol, and SHBG were measured via immunoassay in serum samples from a total of 898 adult men (ages 20-90) participating in the morning examination. As part of the NHANES data collection, DXA scans and measurements of weight, height, and waist circumference were performed by trained staff. Linear regression was used to estimate associations between body size and hormone levels adjusted for potential confounders and NHANES sampling procedures. RESULTS:Total bone area (cm(2)) was inversely associated with total testosterone (ng/mL) [beta = -0.12; p value < 0.01], while bone mineral density (g/cm(2)) was inversely associated with SHBG (nmol/L) [beta = -17.16; p value = 0.01]. Increased percent body fat was associated with lower concentrations of total testosterone [beta = -0.16; p value < 0.01] and SHBG [beta = -1.11; p value < 0.01] and higher concentrations of free estradiol (fg/mL) [beta = 12.52; p value < 0.01]. CONCLUSIONS: Clinical measures of body fat (measured via DXA scan) and anthropometric measures of body fat (BMI and waist circumference) provided similar inferences regarding the association between increased body fat and hormone levels in men. Increased body fat was associated with lower circulating levels of testosterone (total and free) and SHBG and higher circulating levels of free estradiol in men, while decreased bone mineral density was associated with higher circulating levels of SHBG.
RCT Entities:
PURPOSE: To evaluate the association of body size-captured via whole-body dual-energy X-ray absorptiometry (DXA) and physical measurement-with serum sex steroid hormones and sex hormone binding globulin (SHBG), we utilized cross-sectional data and serum samples from the National Health and Nutrition Examination Survey (NHANES; 1999-2004). METHODS:Testosterone, androstanediol glucuronide (3-alpha-diol-G), estradiol, and SHBG were measured via immunoassay in serum samples from a total of 898 adult men (ages 20-90) participating in the morning examination. As part of the NHANES data collection, DXA scans and measurements of weight, height, and waist circumference were performed by trained staff. Linear regression was used to estimate associations between body size and hormone levels adjusted for potential confounders and NHANES sampling procedures. RESULTS: Total bone area (cm(2)) was inversely associated with total testosterone (ng/mL) [beta = -0.12; p value < 0.01], while bone mineral density (g/cm(2)) was inversely associated with SHBG (nmol/L) [beta = -17.16; p value = 0.01]. Increased percent body fat was associated with lower concentrations of total testosterone [beta = -0.16; p value < 0.01] and SHBG [beta = -1.11; p value < 0.01] and higher concentrations of free estradiol (fg/mL) [beta = 12.52; p value < 0.01]. CONCLUSIONS: Clinical measures of body fat (measured via DXA scan) and anthropometric measures of body fat (BMI and waist circumference) provided similar inferences regarding the association between increased body fat and hormone levels in men. Increased body fat was associated with lower circulating levels of testosterone (total and free) and SHBG and higher circulating levels of free estradiol in men, while decreased bone mineral density was associated with higher circulating levels of SHBG.
Authors: Sabine Rohrmann; Meredith S Shiels; David S Lopez; Nader Rifai; William G Nelson; Norma Kanarek; Eliseo Guallar; Andy Menke; Corinne E Joshu; Manning Feinleib; Siobhan Sutcliffe; Elizabeth A Platz Journal: Cancer Causes Control Date: 2011-06-16 Impact factor: 2.506
Authors: M L Slattery; Rachel Ballard-Barbash; Sandra Edwards; Bette J Caan; John D Potter Journal: Cancer Causes Control Date: 2003-02 Impact factor: 2.506
Authors: Dan Mellström; Olof Johnell; Osten Ljunggren; Anna-Lena Eriksson; Mattias Lorentzon; Hans Mallmin; Anna Holmberg; Inga Redlund-Johnell; Eric Orwoll; Claes Ohlsson Journal: J Bone Miner Res Date: 2006-04-05 Impact factor: 6.741
Authors: Howard A Fink; Susan K Ewing; Kristine E Ensrud; Elizabeth Barrett-Connor; Brent C Taylor; Jane A Cauley; Eric S Orwoll Journal: J Clin Endocrinol Metab Date: 2006-07-18 Impact factor: 5.958
Authors: Cindy Ke Zhou; Denise Young; Edward D Yeboah; Sally B Coburn; Yao Tettey; Richard B Biritwum; Andrew A Adjei; Evelyn Tay; Shelley Niwa; Ann Truelove; Judith Welsh; James E Mensah; Robert N Hoover; Isabell A Sesterhenn; Ann W Hsing; Shiv Srivastava; Michael B Cook Journal: Am J Epidemiol Date: 2017-12-15 Impact factor: 4.897
Authors: Daniela A Rubin; Hoang N Pham; Eric S Adams; Andrew R Tutor; Anthony C Hackney; Jared W Coburn; Daniel A Judelson Journal: Eur J Appl Physiol Date: 2015-01-30 Impact factor: 3.078
Authors: Louise A Brinton; Tim J Key; Laurence N Kolonel; Karin B Michels; Howard D Sesso; Giske Ursin; Stephen K Van Den Eeden; Shannon N Wood; Roni T Falk; Dominick Parisi; Chantal Guillemette; Patrick Caron; Véronique Turcotte; Laurel A Habel; Claudine J Isaacs; Elio Riboli; Elisabete Weiderpass; Michael B Cook Journal: J Clin Oncol Date: 2015-05-11 Impact factor: 44.544
Authors: Jessica L Petrick; Paula L Hyland; Patrick Caron; Roni T Falk; Ruth M Pfeiffer; Sanford M Dawsey; Christian C Abnet; Philip R Taylor; Stephanie J Weinstein; Demetrius Albanes; Neal D Freedman; Susan M Gapstur; Gary Bradwin; Chantal Guillemette; Peter T Campbell; Michael B Cook Journal: J Natl Cancer Inst Date: 2019-01-01 Impact factor: 13.506
Authors: David S Lopez; Sabine Rohrmann; Sarah B Peskoe; Corinne E Joshu; Konstantinos K Tsilidis; Elizabeth Selvin; Adrian S Dobs; Norma Kanarek; Steven Canfield; William G Nelson; Elizabeth A Platz Journal: Int J Endocrinol Metab Date: 2017-04-22
Authors: Prabin Gyawali; Sean A Martin; Leonie K Heilbronn; Andrew D Vincent; Alicia J Jenkins; Andrzej S Januszewski; Anne W Taylor; Robert J T Adams; Peter D O'Loughlin; Gary A Wittert Journal: PLoS One Date: 2018-07-11 Impact factor: 3.240